← All trials
NCT00518596
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2005
- Primary completion
- —
- Completion date
- Aug 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 284
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Child Health and Human Development (NICHD)Lead sponsor
- University of MarylandOverall official - principal investigator
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
- National Institute of Dental and Craniofacial Research (NIDCR)Collaborator
- National Cancer Institute (NCI)Collaborator
- RTI InternationalCollaborator
- University of MarylandCollaborator
- Bill and Melinda Gates FoundationCollaborator
- Department of Health and Family Welfare, OrissaCollaborator
- SCB Medical College, CuttackCollaborator
- Capital Hospital, BhubaneswarCollaborator
- Ispat General Hospital, RourkelaCollaborator
- Kalinga Hospital, BhubaneswarCollaborator
- Topiwala National Medical CollegeCollaborator
- All India Institute of Medical SciencesCollaborator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.